Marizyme, Inc.
MRZM · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -78.2% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -566.4% | -77.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -5,646% | -5,205.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -18,949.9% | -6,486.4% |
| EPS Diluted | -0.015 | -0.031 | -0.047 | -0.19 |
| % Growth | 51.8% | 34.5% | 75.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |